Quick Answer
AMGEN INC reported Stockholders Equity of $8.66 billion for fiscal year 2025.
AMGEN INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $8.66B | +47.3% |
| 2024 | $5.88B | -5.7% |
| 2023 | $6.23B | +70.2% |
| 2022 | $3.66B | -45.4% |
| 2021 | $6.70B | -28.8% |
| 2020 | $9.41B | -2.7% |
| 2019 | $9.67B | -22.6% |
| 2018 | $12.50B | -50.5% |
| 2017 | $25.24B | -15.5% |
| 2016 | $29.88B | +6.4% |
| 2015 | $28.08B | +8.9% |
| 2014 | $25.78B | +16.7% |
| 2013 | $22.10B | +15.9% |
| 2012 | $19.06B | +0.2% |
| 2011 | $19.03B | -20.5% |
| 2010 | $23.94B | +5.6% |
| 2009 | $22.67B | +8.5% |
| 2008 | $20.89B | +12.8% |
| 2007 | $18.51B | -6.7% |
| 2006 | $19.84B | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $9.62B | +27.8% | +29.5% |
| June 30, 2025 | $7.43B | +25.4% | +19.7% |
| March 31, 2025 | $6.21B | +23.6% | +5.6% |
| December 31, 2024 | $5.88B | -5.7% | -21.9% |
| September 30, 2024 | $7.53B | -1.7% | +27.0% |
| June 30, 2024 | $5.92B | -12.6% | +18.0% |
| March 31, 2024 | $5.02B | -6.1% | -19.4% |
| December 31, 2023 | $6.23B | +70.2% | -18.6% |
- AMGEN INC showed an increase of +47.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2006–2025 period, AMGEN INC’s stockholders equity has declined by 56.4% (from $19.84 billion to $8.66 billion).
- The most recent figure is from AMGEN INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: